当前位置:首页 - 行情中心 - 金域医学(603882) - 财务分析 - 现金流量表

金域医学

(603882)

  

流通市值:145.26亿  总市值:146.25亿
流通股本:4.60亿   总股本:4.63亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,066,685,526.721,436,169,512.277,555,453,022.145,476,491,762.88
  收到的税费返还78,832,793.921,110,467.78721,980.933,262,723.06
  收到其他与经营活动有关的现金68,235,534.5239,847,254.38109,699,462.2480,099,738.47
  经营活动现金流入小计3,213,753,855.161,477,127,234.437,665,874,465.315,559,854,224.41
  购买商品、接受劳务支付的现金1,393,331,272.69681,236,082.143,837,467,210.192,807,998,882.48
  支付给职工以及为职工支付的现金859,311,400.07452,272,363.431,900,111,957.871,410,264,551.73
  支付的各项税费110,819,907.0642,057,574.7183,388,043.09164,745,945.21
  支付其他与经营活动有关的现金499,821,783.89247,056,522.01838,559,732.58864,929,670.17
  经营活动现金流出小计2,863,284,363.711,422,622,542.286,759,526,943.735,247,939,049.59
  经营活动产生的现金流量净额350,469,491.4554,504,692.15906,347,521.58311,915,174.82
二、投资活动产生的现金流量:
  收回投资收到的现金10,335,197.437,073,522.610302,811.7
  取得投资收益收到的现金1,725,775.881,383,598.951,509,860.64371,620.56
  处置固定资产、无形资产和其他长期资产收回的现金净额1,181,768.55590,262.7515,202,038.682,876,369.82
  处置子公司及其他营业单位收到的现金净额--0-
  投资活动现金流入小计13,242,741.869,047,384.3116,711,899.323,550,802.08
  购建固定资产、无形资产和其他长期资产支付的现金174,236,937.49106,474,281.8446,361,442.37347,168,189.1
  投资支付的现金38,333,333.34-25,879,130.3617,802,265.22
  取得子公司及其他营业单位支付的现金--0-
  支付其他与投资活动有关的现金--0-
  投资活动现金流出小计212,570,270.83106,474,281.8472,240,572.73364,970,454.32
  投资活动产生的现金流量净额-199,327,528.97-97,426,897.49-455,528,673.41-361,419,652.24
三、筹资活动产生的现金流量:
  取得借款收到的现金83,745,121.5527,458,021.55368,838,299.27285,648,283.27
  筹资活动现金流入小计83,745,121.5527,458,021.55368,838,299.27285,648,283.27
  偿还债务支付的现金29,997,513.896,425,57098,621,943.8971,550,000
  分配股利、利润或偿付利息支付的现金426,807,753.62410,074,307.13427,880,350.28417,575,142.55
  其中:子公司支付给少数股东的股利、利润14,200,000-8,314,928.692,280,000
  支付其他与筹资活动有关的现金28,298,735.9213,132,392.11331,136,524.73259,635,182.9
  筹资活动现金流出小计485,104,003.43429,632,269.24857,638,818.9748,760,325.45
  筹资活动产生的现金流量净额-401,358,881.88-402,174,247.69-488,800,519.63-463,112,042.18
四、汇率变动对现金及现金等价物的影响-7,028,422.73-1,510,271.7110,832,079.85-1,986,636.68
五、现金及现金等价物净增加额-257,245,342.13-446,606,724.74-27,149,591.61-514,603,156.28
  加:期初现金及现金等价物余额2,422,524,549.622,422,524,549.622,449,674,141.232,449,674,141.23
  期末现金及现金等价物余额2,165,279,207.491,975,917,824.882,422,524,549.621,935,070,984.95
补充资料:
  净利润-96,868,140.52--414,703,700.92-
  资产减值准备-125,413.97-72,623,272.86-
  固定资产和投资性房地产折旧160,961,885.9-434,946,280.78-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧160,961,885.9-434,946,280.78-
  无形资产摊销6,408,546.82-10,264,811.97-
  长期待摊费用摊销44,551,120.84-98,396,472.41-
  处置固定资产、无形资产和其他长期资产的损失-2,441,961.14--6,364,363.75-
  固定资产报废损失439,518.91-149,958,864.97-
  公允价值变动损失--30,798,817.27-
  财务费用8,006,679.54-18,223,688.51-
  投资损失-2,008,308.27-37,083,018.3-
  递延所得税-48,843,708.63--119,864,087.04-
  其中:递延所得税资产减少-45,647,654.21--90,314,044.91-
    递延所得税负债增加-3,196,054.42--29,550,042.13-
  存货的减少7,591,803.02-49,892,124.76-
  经营性应收项目的减少78,365,080.54-263,523,149.7-
  经营性应付项目的增加-151,710,293.42--413,541,664.33-
  其他28,298,735.92--33,186,128.1-
  现金的期末余额2,165,279,207.49-2,422,524,549.62-
  减:现金的期初余额2,422,524,549.62-2,449,674,141.23-
  现金及现金等价物的净增加额-257,245,342.13--27,149,591.61-
公告日期2025-08-232025-04-262025-04-262024-10-31
审计意见(境内)标准无保留意见
TOP↑